BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 12487913)

  • 1. [Effects of adenovirus-mediated HSV-tk/GCV system on lens epithelium].
    Wang B; Weng J
    Zhonghua Yan Ke Za Zhi; 2002 Oct; 38(10):618-22. PubMed ID: 12487913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bicistronic lentiviral vector-mediated herpes simplex virus thymidine kinase/ganciclovir system on human lens epithelial cells.
    Yang J; Liu TJ; Lu Y
    Curr Eye Res; 2007 Jan; 32(1):33-42. PubMed ID: 17364733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of lentivirus-mediated suicide gene therapy on lens epithelial cells].
    Yang J; Lu Y; Guo LH; Liu TJ; Mo XF
    Zhonghua Yan Ke Za Zhi; 2007 Sep; 43(9):810-6. PubMed ID: 18070527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The adenovirus-mediated HSV-TK/GCV suicide gene system in the treatment of tongue carcinoma cell line].
    Huang H; Wang A
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Nov; 36(6):457-60. PubMed ID: 11930726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
    Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Killing effect of adenovirus vector-mediated herpes simplex virus thymidine kinase gene recombinant construct on various cancer cells].
    Zhou JF; Chen G; Lu YP; Wang SX; Ma D
    Ai Zheng; 2003 Dec; 22(12):1264-7. PubMed ID: 14693048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
    Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC
    Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-proliferative effect of herpes simplex virus thymidine kinase gene system on human Tenon capsule fibroblasts in vitro].
    Wang JB; Ge J; Liu BQ; Huang B; Wei YT
    Zhonghua Yan Ke Za Zhi; 2006 Mar; 42(3):212-7. PubMed ID: 16643751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase genes expressed in vascular endothelial cells].
    Liu XP; Li BJ; Zhang C
    Ai Zheng; 2006 Feb; 25(2):179-84. PubMed ID: 16480582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
    Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D
    Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated suicide gene therapy for experimental bladder cancer.
    Sutton MA; Berkman SA; Chen SH; Block A; Dang TD; Kattan MW; Wheeler TM; Rowley DR; Woo SL; Lerner SP
    Urology; 1997 Feb; 49(2):173-80. PubMed ID: 9037277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental studies on the characteristics of suicide gene system HSV-tk/GCV and its effect on dendritic cells].
    Wang X; Li L; Feng K; Bai L; Pei X
    Zhonghua Xue Ye Xue Za Zhi; 2000 Dec; 21(12):628-31. PubMed ID: 11877036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir.
    Rosenfeld ME; Feng M; Michael SI; Siegal GP; Alvarez RD; Curiel DT
    Clin Cancer Res; 1995 Dec; 1(12):1571-80. PubMed ID: 9815958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of adenovirus-mediated TK/GCV gene therapy in combination with TNF-alpha against murine bladder cancer cells in vitro].
    Shi XH; Tan WL; Zhu WH; Liang ZK; DU YJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):750-3. PubMed ID: 18504196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro killing effect of mutant thymidine kinase mediated by lentiviral vector on T lymphocytes].
    Xu KL; Pan XY; Yang YJ; Lu QX; Li ZY; He XP
    Zhonghua Xue Ye Xue Za Zhi; 2005 Nov; 26(11):678-81. PubMed ID: 16620557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
    Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
    Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lethal effect of adenovirus-mediated HSV-TK gene in combination with hydroxycamptothecin on human bladder cancer in vitro].
    Huang H; Tan WL; Zhu WH; Liang ZK
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):461-4. PubMed ID: 17545031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Killing effect of coexpressing cytosine deaminase and thymidine kinase on rat vascular smooth muscle cells.
    Cao HQ; Meng XM; Liu DQ; Zhao XW; Ding JF
    Chin Med J (Engl); 2004 Oct; 117(10):1464-70. PubMed ID: 15498366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.